Stanley Alkemade
Founder at Worldwide BioMedEx, Inc.
Stanley Alkemade active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BiomedEx Pty Ltd. | President | - | - |
| Worldwide BioMedEx, Inc. | Founder | - | - |
| President | 21/09/2011 | - |
Career history of Stanley Alkemade
Former positions of Stanley Alkemade
| Companies | Position | Start | End |
|---|---|---|---|
| TELESTA THERAPEUTICS INC | Director/Board Member | 01/09/1999 | 05/11/2013 |
| Independent Dir/Board Member | 01/09/1999 | 05/11/2013 | |
NovaVive, Inc.
 NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Director/Board Member | - | - |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | President | 01/01/2007 | - |
Training of Stanley Alkemade
| University of Melbourne | Doctorate Degree |
Statistics
International
| Canada | 5 |
| Australia | 3 |
Operational
| President | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
| BiomedEx Pty Ltd. | |
| Worldwide BioMedEx, Inc. | |
Viron Therapeutics, Inc.
Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Health Technology |
NovaVive, Inc.
NovaVive, Inc. BiotechnologyHealth Technology NovaVive, Inc. provides biotechnology services. The company was founded in 2014 and is headquartered in Belleville, Canada. | Health Technology |
- Stock Market
- Insiders
- Stanley Alkemade
- Experience
